Eluvia Drug-Eluting Vascular Stent
Ranger Paclitaxel-Coated PTA Balloon Catheter
Resources › Data Sheets :
IMPERIAL Data Sheet
View the remarkable results Eluvia achieved in the first head-to-head trial: Eluvia DES vs. Zilver PTX.
2-year results from IMPERIAL
Evaluate the safety and effectiveness of the Boston Scientific Corporation ELUVIA™ Drug-Eluting Vascular Stent System for treating Superficial Femoral Artery (SFA) and/or Proximal Popliteal Artery (PPA) lesions up to 140 mm in length.
RANGER II SFA Pivotal Trial Data Sheet
See the 12-month full cohort results of the Ranger II SFA Pivotal Trial.
COMPARE Clinical Data Sheet
Learn more about the world’s first head-to-head, prospective, multi-center Randomized Controlled Trial (1:1) comparing the lower dose Paclitaxel RANGER DCB (2 µg/mm2) to the higher dose Paclitaxel IN.PACT DCB (3.5 µg/mm2).
Stay Up to Date
Receive emails about the latest drug-eluting technology news, innovations and events in your area.
Explore DE Resources
Get physician perspectives, clinical data sheets and other resources about drug-eluting innovations.
2. Versus 87.0% primary patency in the none/mild calcium arm of the IMPERIAL Calcium Subgroup.